Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes - Wikidata - wikimedia - TriplyDB

Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes

Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes

http://www.wikidata.org/entity/Q33740885

about

Astragalus polysaccharide suppresses doxorubicin-induced cardiotoxicity by regulating the PI3k/Akt and p38MAPK pathways.Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.Epidemiology of "Heart Failure with Recovered Ejection Fraction": What do we do After Recovery?Kyoto Congestive Heart Failure (KCHF) study: rationale and design Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review.Abnormal Global Longitudinal Strain Predicts Future Deterioration of Left Ventricular Function in Heart Failure Patients With a Recovered Left Ventricular Ejection Fraction.Left ventricular assist device-induced reverse remodeling: it's not just about myocardial recovery.Transcriptional patterns of reverse remodeling with left ventricular assist devices: a consistent signature.After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure.Effect of Heart Failure With Preserved Ejection Fraction on Nitric Oxide Metabolites.Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).Reverse remodelling and myocardial recovery in heart failure.Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction.Characteristics and prognosis of heart failure with improved compared with persistently reduced ejection fraction: A systematic review and meta-analyses.Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.Recovery in Patients With Dilated Cardiomyopathy With Loss-of-Function Mutations in the Titin Gene.Gaps in the Heart Failure Guidelines

P2860

Q34438288-DBE07DF0-65C9-4351-AF61-CD18E0529984 Q36728719-782F8310-FAF7-426A-BE7B-8D477D742CB8 Q36757833-16908D0C-E2C4-4C98-8F12-B1949303DE34 Q38373676-89CF088E-6403-44F1-B6DE-47737EE9057C Q38612603-2F3C52D0-85DB-47D2-8658-51248FB2395E Q38643986-5748F934-11F4-41E8-8485-4285E810179C Q38658569-038B5B06-8C34-4023-8A79-A1296105EB63 Q38677002-5BBF6C75-06FA-4940-BB80-16651B1006FA Q38792510-9C71EA26-C599-41DD-993A-E79BF5090585 Q38800048-FE2BB7E5-26AA-4F66-B510-DC45B640D10A Q38807777-B19CC625-9A77-473C-948D-9A8B41FD7BED Q38859108-5A64EEBC-3093-4E0D-9AA9-9029260A5104 Q38977493-95459F98-380D-487C-B1AF-A590BF472D6B Q40541500-7C1C213E-82B6-4F29-8EBE-2D99F6504EED Q41686228-2BCFB926-8556-42A9-8080-2F860C03D3B5 Q47186244-08790D3C-CEB1-478E-AB85-BDE6B6139621 Q47652227-5F98FE6E-20C6-490A-AED0-35909DD908BF Q48119758-3B8589A4-094D-440C-B80A-CB7254BB4407 Q48513189-317DB666-969F-4176-A002-689DEDD5CACA Q50127271-53025371-190F-4639-8D8A-03A8986E8DC4 Q50926906-6BFADAE4-E7E4-49B0-94B6-24808AEDAC84 Q53347615-D06DE323-89BF-4606-8CA8-CA54B34D9A70 Q57630227-E87BEA71-D2BD-45F2-AFBD-F749ED846C5E

P2860

Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes

http://www.wikidata.org/entity/Q33740885

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Heart failure with recovered e ...... tion, biomarkers, and outcomes

@ast

Heart failure with recovered e ...... tion, biomarkers, and outcomes

@en

type

label

Heart failure with recovered e ...... tion, biomarkers, and outcomes

@ast

Heart failure with recovered e ...... tion, biomarkers, and outcomes

@en

prefLabel

Heart failure with recovered e ...... tion, biomarkers, and outcomes

@ast

Heart failure with recovered e ...... tion, biomarkers, and outcomes

@en

P1433

Q33740885-88F5D8D1-1029-41A7-9D60-19F8999CD76C

P1476

Q33740885-2B0BFFBC-175C-4F4A-8373-EEB7A1D1C6F8

P2093

Q33740885-18545BAE-C8D2-4A40-97B2-224DC7C46A40

Q33740885-5A772ADE-3E51-430A-AB88-DD33666806D5

Q33740885-5C449039-5B44-4A1D-818A-77C7D923A293

Q33740885-B2DE9AD2-AE96-402A-B29A-4AB8DFB3ACDC

Q33740885-BD612D9B-443C-4804-8D87-20D75165453E

Q33740885-BFB617A6-2776-4E6B-927A-A01A687D907A

Q33740885-F8A5BB21-3A32-4F26-97BE-2CB97E4B906E

P2860

Q33740885-050368A5-E7EA-4D55-98C8-A55D5F333C8A

Q33740885-066C4433-912F-4A60-8D8B-A07ED7702BD1

Q33740885-0B7B9FD6-85BE-4E93-A323-7E86C6B0DEB5

Q33740885-14013A58-32AE-4A2A-BE63-E51D8A76DFF3

Q33740885-15ACDC39-A972-4AB2-9A40-39AD0967DE6B

Q33740885-181AAFD7-E6CA-4B19-B42C-630EF2642595

Q33740885-2A8C430A-7A15-4643-8051-FB617A3919B8

Q33740885-5A4EF7B5-EEEB-4627-A6ED-16EE15661A38

Q33740885-66AD138C-D247-493E-B0E5-61982E47DD6D

Q33740885-778EA29D-3CA8-4FB4-AC27-94883BDF3CCE

P304

Q33740885-AF70D17B-E18D-402A-860A-D6C6AF57B4C3

P31

Q33740885-9750BEA4-1349-4B6B-95EB-8CDB407C358E

P356

Q33740885-88BBD806-C71B-4566-B27C-72A83BBB11BE

P407

Q33740885-08B2D12F-AFBB-4872-B36E-0DE53331B790

P433

Q33740885-987C8050-C69F-46D8-BFBE-4CFD016EC992

P478

Q33740885-D363EED5-EC8C-43B9-A260-0B30CBC2378F

P50

Q33740885-9D7587F7-0B69-4778-9AAB-125DE00B449E

P577

Q33740885-6674EA52-C7D5-4173-BBB2-0BB3FDDB1769

P698

Q33740885-7C33B509-2C44-44CC-A073-59F82E050FB7

P921

Q33740885-1EADC57C-670C-40A2-917F-6DA5A402BCBB

Q33740885-BDA7BEA2-985F-454E-A80F-ADAC4C537C53

P932

Q33740885-5DE0CE43-278C-4052-B288-5855B95E21E2

P356

CIRCULATIONAHA.113.006855

P1433

P1476

Heart failure with recovered e ...... tion, biomarkers, and outcomes

@en

P2093

Anupam Basuray

http://www.w3.org/2001/XMLSchema#string

Benjamin French

http://www.w3.org/2001/XMLSchema#string

Bonnie Ky

http://www.w3.org/2001/XMLSchema#string

Caroline Olt

http://www.w3.org/2001/XMLSchema#string

Esther Vorovich

http://www.w3.org/2001/XMLSchema#string

James C Fang

http://www.w3.org/2001/XMLSchema#string

Thomas P Cappola

http://www.w3.org/2001/XMLSchema#string

P2860

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure

Trends in prevalence and outcome of heart failure with preserved ejection fraction

The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.

A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis.

Multiple biomarkers for risk prediction in chronic heart failure.

Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions

Bridge to recovery: understanding the disconnect between clinical and biological outcomes.

Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy.

Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery.

P304

2380-2387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.113.006855

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24799515

http://www.w3.org/2001/XMLSchema#string

P921

P932

4053508

http://www.w3.org/2001/XMLSchema#string